Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Endocrinology

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/EN.2006-1269PMID 17363451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The MEK/ERK cascade: from signaling specificity to diverse functions.

  2007cited by this paper
• Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species‐mediated activation of ERK

  2007cited by this paper
• Signaling regulation of genomic and nongenomic functions of estrogen receptors.

  2006cited by this paper
• Functional estrogen receptors in the mitochondria of breast cancer cells.

  2006cited by this paper
• Estrogen induces phospholipase A2 activation through ERK1/2 to mobilize intracellular calcium in MCF-7 cells.

  2006cited by this paper
• Nature of functional estrogen receptors at the plasma membrane.

  2006cited by this paper
• Membrane initiated estrogen signaling in breast cancer.

  2006cited by this paper
• Antagonist-induced, activation function-2-independent estrogen receptor α phosphorylation

  2006cited by this paper
• Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

  2006cited by this paper
• Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.

  2006cited by this paper
• Detection of a raft-located estrogen receptor-like protein distinct from ER alpha.

  2006cited by this paper
• Integration of the extranuclear and nuclear actions of estrogen.

  2005cited by this paper
• Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.

  2005cited by this paper
• 17beta-estradiol activation of the c-Jun N-terminal kinase pathway leads to down-regulation of class II major histocompatibility complex expression.

  2005cited by this paper
• Regulation of signal transduction pathways by estrogen and progesterone.

  2005cited by this paper
• Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells

  2005influential reference
• Transient Versus Sustained Phosphorylation and Nuclear Accumulation of ERKs Underlie Anti-Versus Pro-apoptotic Effects of Estrogens*

  2005cited by this paper
• Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin

  2005cited by this paper
• Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt.

  2004cited by this paper
• Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells

  2004cited by this paper
• Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.

  2004cited by this paper
• Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

  2004cited by this paper
• Plasma membrane estrogen receptors exist and functions as dimers.

  2004cited by this paper
• Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway.

  2004cited by this paper
• Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen.

  2003cited by this paper
• Various Phosphorylation Pathways, Depending on Agonist and Antagonist Binding to Endogenous Estrogen Receptor α (ERα), Differentially Affect ERα Extractability, Proteasome-Mediated Stability, and Transcriptional Activity in Human Breast Cancer Cells

  2003cited by this paper
• The Effects of Tamoxifen and Toremifene on Bone Cells Involve Changes in Plasma Membrane Ion Conductance

  2003cited by this paper
• Comparison of the changes in adenine nucleotides of rat liver mitochondria induced by tamoxifen and 4-hydroxytamoxifen.

  2003cited by this paper
• Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

  2003cited by this paper
• Proximal Events in Signaling by Plasma Membrane Estrogen Receptors*

  2003cited by this paper
• Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.

  2003cited by this paper
• ERβ Has Nongenomic Action in Caveolae

  2002cited by this paper
• MAPK signal pathways in the regulation of cell proliferation in mammalian cells

  2002cited by this paper
• Calmodulin is a selective modulator of estrogen receptors.

  2002cited by this paper
• Characterization of the Biological Roles of the Estrogen Receptors, ERα and ERβ, in Estrogen Target Tissues in Vivo through the Use of an ERα-Selective Ligand

  2002cited by this paper
• ERK Activation Mediates Cell Cycle Arrest and Apoptosis after DNA Damage Independently of p53*

  2002cited by this paper
• Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand.

  2002cited by this paper
• Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.

  2002cited by this paper
• BRCA1-induced Apoptosis Involves Inactivation of ERK1/2 Activities*

  2002cited by this paper
• The role of mitogen-activated protein (MAP) kinase in breast cancer.

  2002cited by this paper
• Molecular interpretation of ERK signal duration by immediate early gene products

  2002cited by this paper
• Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.

  2002influential reference
• Prolonged Nuclear Retention of Activated Extracellular Signal-regulated Protein Kinase Promotes Cell Death Generated by Oxidative Toxicity or Proteasome Inhibition in a Neuronal Cell Line*

  2002cited by this paper
• ER-X: A Novel, Plasma Membrane-Associated, Putative Estrogen Receptor That Is Regulated during Development and after Ischemic Brain Injury

  2002cited by this paper
• Tamoxifen elicits its anti-estrogen effects in growth plate chondrocytes by inhibiting protein kinase C.

  2002cited by this paper
• Rapid actions of plasma membrane estrogen receptors.

  2001influential reference
• Identification and characterization of membrane estrogen receptor from MCF7 estrogen-target cells

  2001cited by this paper
• Signal transduction through the ras/Erk pathway is essential for the mycoestrogen zearalenone‐induced cell‐cycle progression in MCF‐7 cells

  2001cited by this paper
• Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells

  2001cited by this paper
• Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency.

  2001cited by this paper
• Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.

  2001cited by this paper
• 17-beta-estradiol induces an inhibitor of active caspases.

  2001cited by this paper
• Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line

  2001cited by this paper
• Tamoxifen but Not 4-Hydroxytamoxifen Initiates Apoptosis in p53(−) Normal Human Mammary Epithelial Cells by Inducing Mitochondrial Depolarization*

  2001cited by this paper
• The Raf/MEK/ERK pathway: new concepts of activation

  2001cited by this paper
• 17-β-Estradiol Induces an Inhibitor of Active Caspases

  2001cited by this paper
• Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells.

  2001cited by this paper
• Linkage of Rapid Estrogen Action to MAPK Activation by ER-Shc Association and Shc Pathway Activation

  2001cited by this paper
• The Potentiation of Estrogen on Insulin-like Growth Factor I Action in MCF-7 Human Breast Cancer Cells Includes Cell Cycle Components*

  2000cited by this paper
• Nuclear Export of Map Kinase (ERK) Involves a Map Kinase Kinase (Mek-Dependent) Active Transport Mechanism

  2000cited by this paper
• 17β-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence

  2000cited by this paper
• Membrane Estrogen Receptor Engagement Activates Endothelial Nitric Oxide Synthase via the PI3-Kinase–Akt Pathway in Human Endothelial Cells

  2000cited by this paper
• Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.

  2000cited by this paper
• Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors.

  2000cited by this paper
• Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells.

  2000cited by this paper
• Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells.

  2000cited by this paper
• Mechanisms of Transcriptional Activation of bcl-2Gene Expression by 17β-Estradiol in Breast Cancer Cells*

  1999cited by this paper
• Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

  1999cited by this paper
• Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells.

  1999cited by this paper
• Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.

  1999cited by this paper
• Paradoxical regulation of Bcl-2 family proteins by 17β-oestradiol in human breast cancer cells MCF-7

  1999cited by this paper
• Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

  1999cited by this paper
• The breast cancer prevention trial: should women at risk take tamoxifen?

  1999cited by this paper
• Hydrogen Peroxide Activation of Multiple Mitogen‐Activated Protein Kinases in an Oligodendrocyte Cell Line

  1999cited by this paper
• Current status of tamoxifen use: An update for the surgical oncologist

  1999cited by this paper
• Involvement of Ca2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells.

  1999cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• 'A Big Deal,' But a Complex Hand to Play

  1998influential reference
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Tamoxifen inhibits induction of the mitochondrial permeability transition by Ca2+ and inorganic phosphate.

  1998cited by this paper
• Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma.

  1997cited by this paper
• Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells

  1997cited by this paper
• An essential role for free radicals and derived species in signal transduction

  1997cited by this paper
• Activation of Signal Transduction Kinases by Tamoxifen

  1997cited by this paper
• Phospholipase C β and Membrane Action of Calcitriol and Estradiol*

  1997cited by this paper
• Activation of Mitogen-activated Protein Kinase by HO

  1996cited by this paper
• Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.

  1996cited by this paper
• Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

  1995cited by this paper
• Membrane estrogen receptors identified by multiple antibody labeling and impeded‐ligand binding

  1995cited by this paper
• Participation of Reactive Oxygen Species in the Lysophosphatidic Acid-stimulated Mitogen-activated Protein Kinase Kinase Activation Pathway (*)

  1995cited by this paper
• Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

  1995cited by this paper
• Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines

  1994cited by this paper
• Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects.

  1989cited by this paper
• Metabolic and proliferative responses to estrogen by hepatocytes selected for plasma membrane binding‐sites specific for estradiol‐17β

  1979cited by this paper
• Endometrial cell calcium and oestrogen action

  1975cited by this paper

• Itaconate targets the ERK2 signal to suppress estrogen receptor-positive breast cancer cell growth.

  2025cites this paper
• Toxicity and antiproliferative activity assessment of a novel compound Zr I isolated from Zingiber roseum Rosc

  2025cites this paper
• Tamoksifen direncine karşı borik asit: MCF-7 hücrelerinde kombine sitotoksik etkinin in vitro analizi

  2025cites this paper
• Research Advances in Chaperone-Mediated Autophagy (CMA) and CMA-Based Protein Degraders.

  2025cites this paper
• TRP channels and breast cancer: the role of TRPs in the pathophysiological development

  2025cites this paper
• Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review

  2024cites this paper
• ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer

  2024cites this paper
• Imatinib-loaded Pectin-modified magnetic nanoparticles as a smart pH-responsive therapeutic system against proliferation of gastric cancer cell line

  2024cites this paper
• Synergistic anticancer effects and reduced genotoxicity of silver nanoparticles and tamoxifen in breast cancer cells

  2024cites this paper
• Comparison of Anticancer Activity Between Thymoquinone and Tamoxifen , Thymoquinone + Tamoxifen 0n Mcf -7 Cell Line of Human Breast Cancer –An Invitro Study.

  2024cites this paper
• Biogenic copper oxide nanoparticles from Bacillus coagulans induced reactive oxygen species generation and apoptotic and anti-metastatic activities in breast cancer cells

  2023cites this paper
• In Vitro Evaluation of Cytotoxic and Antitumor Activities of The Tamoxifen and Doxorubicin Combination on MCF-7 and BT-474 Breast Cancer Cell Lines

  2023cites this paper
• Role of the voltage-gated sodium channel Nav1.6 in glioma and candidate drugs screening

  2023cites this paper
• Anticancer Properties of 3-Dietoxyphosphorylfuroquinoline-4,9-dione

  2023cites this paper
• The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells

  2023cites this paper
• Krüppel-like factor 9 (KLF9) links hormone dysregulation and circadian disruption to breast cancer pathogenesis

  2023cites this paper
• The Predictive and Prognostic Role of RAS–RAF–MEK–ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets

  2022cites this paper
• SH003 overcomes drug resistance and immune checkpoints by inhibiting JAK-STAT3 signaling in MCF7/ADR cells

  2021cites this paper
• Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α

  2021cites this paper
• Non-genomic signaling of steroid receptors in cancer.

  2021cites this paper
• ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer

  2021cites this paper
• Complex interactions of lovastatin with 10 chemotherapeutic drugs: a rigorous evaluation of synergism and antagonism

  2020cites this paper
• ERK-Mediated Phosphorylation of EZH2 Regulates HER2 Expression on Long-term Genistein-induced Acquired Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer Cells

  2020cites this paper
• Identifying the Responses from the Estrogen Receptor-Expressed MCF7 Cells Treated in Anticancer Drugs of Different Modes of Action Using Live-Cell FTIR Spectroscopy

  2020cites this paper
• Development and evaluation of polymeric micelle containing tablet formulation for poorly water-soluble drug: tamoxifen citrate

  2020cites this paper
• Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion

  2020cites this paper
• The role of ERα36 in cell type-specific functions of estrogen and cancer development.

  2020cites this paper
• The tissue expression of MCT3, MCT8, and MCT9 genes in women with breast cancer

  2020cites this paper
• Chapter 4 Targeting the Autophagy Process in Breast Cancer Development and Treatment

  2019cites this paper
• Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson’s

  2019influential citation
• One step conjugation of some chemotherapeutic drugs to the biologically produced gold nanoparticles and assessment of their anticancer effects

  2019cites this paper
• Design and development of microemulsion systems of a new antineoplaston A10 analog for enhanced intravenous antitumor activity: In vitro characterization, molecular docking, 125I‐radiolabeling and in vivo biodistribution studies

  2018cites this paper
• Cucurbitacin D exhibits its anti-cancer effect in human breast cancer cells by inhibiting Stat3 and Akt signaling

  2018cites this paper
• Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing

  2018cites this paper
• Low serum gastrin associated with ER+ breast cancer development via inactivation of CCKBR/ERK/P65 signaling

  2018cites this paper
• Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping

  2017cites this paper
• Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells

  2017cites this paper
• STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells

  2017cites this paper
• Recent synthetic and medicinal perspectives of tryptanthrin.

  2017cites this paper
• Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety

  2017cites this paper
• Hydrophobic myristic acid modified PAMAM dendrimers augment the delivery of tamoxifen to breast cancer cells

  2016cites this paper
• Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo

  2016cites this paper
• Simultaneous cytosolic delivery of a chemotherapeutic and siRNA using nanoparticle-stabilized nanocapsules

  2016cites this paper
• Could Caffeic Acid Phenethyl Ester Expand the Antitumor Effect of Tamoxifen in Breast Carcinoma?

  2016cites this paper
• Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma

  2016cites this paper
• Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2

  2016cites this paper
• An in vitro model for the development of acquired tamoxifen resistance

  2016cites this paper
• Tamoxifen promotes differentiation of oligodendrocyte progenitors in vitro.

  2016cites this paper
• Uncovering New Roles For The Aryl Hydrocarbon Receptor (AHR) In Breast Cancer

  2016influential citation
• The potential role of the oxidoreductase, NQO2, in breast cancer

  2015cites this paper
• Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells

  2015cites this paper
• Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk

  2015cites this paper
• Targeting the Autophagy Process in Breast Cancer Development and Treatment

  2015cites this paper
• Non-genomic actions of estradiol and 4-OH-tamoxifen on murine breast cancer cells.

  2015influential citation
• Anti-carcinogenic effects of ethanolic extracts from root and shoot of Lupinus angustifolius on breast carcinoma cell lines MCF-7 and BT20

  2015cites this paper
• Selective estrogen receptor modulators and betulinic acid act synergistically to target ERα and SP1 transcription factor dependent Pygopus expression in breast cancer

  2015cites this paper
• Human somatostatin receptor-3 distinctively induces apoptosis in MCF-7 and cell cycle arrest in MDA-MB-231 breast cancer cells.

  2015cites this paper
• Redox biology in normal cells and cancer: restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment.

  2015cites this paper
• In vitro effects of tamoxifen on adipose‐derived stem cells

  2015cites this paper
• Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells

  2015cites this paper
• Cytosolic phospholipase A 2 activation correlates with HER 2 overexpression and mediates estrogen-dependent breast cancer cell growth

  2015cites this paper
• Low voltage nanosecond electroporation for breast cancer treatment: an in vitro study

  2014cites this paper
• Differential toxicological endpoints of di(2-ethylhexyl) phthalate (DEHP) exposure in MCF-7 and MDA-MB-231 cell lines: possible estrogen receptor alpha (ERalpha) independent modulations.

  2014cites this paper
• miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1

  2014cites this paper
• The Importance of Autophagy Regulation in Breast Cancer Development and Treatment

  2014cites this paper
• Expression and Regulation of Prostate Apoptosis Response-4 (Par-4) in Human Glioma Stem Cells in Drug-Induced Apoptosis

  2014cites this paper
• Differential toxicological endpoints of di(2-ethylhexyl) phthalate (DEHP) exposure in MCF-7 and MDA-MB-231 cell lines: Possible estrogen receptor α (ERα) independent modulations

  2014cites this paper
• Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.

  2014cites this paper
• The Synthetic Tryptanthrin Analogue Suppresses STAT3 Signaling and Induces Caspase Dependent Apoptosis via ERK Up Regulation in Human Leukemia HL-60 Cells

  2014cites this paper
• In vitro and in vivo effects of xanthorrhizol on human breast cancer MCF-7 cells treated with tamoxifen.

  2014cites this paper
• ERK/CANP rapid signaling mediates 17β-estradiol-induced proliferation of human breast cancer cell line MCF-7 cells.

  2014cites this paper
• Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells

  2013cites this paper
• Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel

  2013cites this paper
• Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells

  2013cites this paper
• Fucoidan Extract Enhances the Anti-Cancer Activity of Chemotherapeutic Agents in MDA-MB-231 and MCF-7 Breast Cancer Cells

  2013cites this paper
• Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells

  2013cites this paper
• Diffusion Weighted Imaging Evaluated the Early Therapy Effect of Tamoxifen in an MNU-Induced Mammary Cancer Rat Model

  2013cites this paper
• Inhibitory effects of tamoxifen and doxorubicin, alone and in combination, on the proliferation of the MG63 human osteosarcoma cell line

  2013cites this paper
• Potencial estrogênico, antimutagênico e antigenotóxico de extratos e substâncias isoladas do gênero Syngonanthus (Eriocaulaceae) e efeito inibidor na expressão de genes por xantonas de Syngonanthus nitens

  2013cites this paper
• Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.

  2012cites this paper
• In vitro antimetastatic activity of koetjapic acid against breast cancer cells.

  2012cites this paper
• The Roles of Monoamine Oxidase-A and p38(MAPK) in Breast Cancer

  2012cites this paper
• Apoptosis induced in human breast cancer cell line by Acanthaster planci starfish extract compared to tamoxifen

  2012cites this paper
• INVESTIGATION OF THE ROLES OF ATM AND ATR IN TAMOXIFEN- INDUCED APOPTOSIS IN 4T1 MOUSE BREAST CANCER CELLS

  2012cites this paper
• DIFFERENTIAL SENSITIVITY EVALUATION OF MCF-7 AND MDA-MB-231 HUMAN BREAST CANCER CELLS EXPOSED TO TAMOXIFEN ALONE AND IN COMBINATION WITH ESTRADIOL

  2012cites this paper
• ERK1/2 and Akt pathway activated during (3R, 6R)‐bassiatin(1)‐induced apoptosis in MCF‐7 cells

  2012cites this paper
• Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells

  2012cites this paper
• Proteogenomic evidence for β‐oxidation of plant‐derived 3‐phenylpropanoids in “Aromatoleum aromaticum” EbN1

  2012cites this paper
• Ribonuclease-Activated Cancer Prodrug.

  2012cites this paper
• Development, Characterization, and In Vitro Evaluation of Tamoxifen Microemulsions

  2012cites this paper
• Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20

  2012cites this paper
• Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives

  2012cites this paper
• Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer

  2012cites this paper
• Effect of tamoxifen on extracellular signal-regulated kinases in the urethra of castrated female rats.

  2012cites this paper
• Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.

  2012cites this paper
• The effects of different lignans and isoflavones, tested as aglycones and glycosides, on hormone receptor-positive and -negative breast carcinoma cells in vitro

  2011cites this paper
• Estrogenic Activity of the Polybrominated Diphenyl Ether Flame Retardant Mixture de-71

  2011cites this paper
• Mechanisms of 4-hydroxytamoxifen-induced Apoptosis in Rhabdomyosarcoma Cells

  2011cites this paper
• Östradiol vermittelte Effekte auf die Proliferation östrogenrezeptorpositiver Mammakarzinomzellen

  2011cites this paper
• Tamoxifen and its new derivatives in cancer research.

  2011cites this paper